KKR (KKR) has been rounding up private lenders offering a combination of senior and subordinated debt to help fund its proposed purchase of Karo Healthcare, bypassing traditional banks, Bloomberg reported on Wednesday, citing people with knowledge of the matter.
Apollo Global Management (APO) is leading the group of private lenders that also includes Goldman Sachs (GS), JPMorgan Chase (JPM) and Jefferies (JEF) along with privately held CVC and KKR's private credit unit, the sources said.
KKR announced plans to acquire Stockholm-based Karo on April 9, buying the specialty pharmaceuticals company from EQT as Karo continues to expand beyond its Scandinavian roots and shift its strategic focus to consumer health care. The companies did not disclose financial details of the transaction but the Bloomberg report said KKR has arranged about 1.1 billion euros ($1.25 billion) in funding for the deal.
KKR and all of the lenders did not immediately respond to requests from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 106.76, Change: +4.48, Percent Change: +4.38
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。